AEON Biopharma (AEON) Competitors $0.68 -0.05 (-6.54%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.68 0.00 (-0.25%) As of 08/1/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEON vs. MAAQ, SNYR, RANI, DYAI, ESLA, RNTX, PMN, BDRX, ITRM, and KZRShould you be buying AEON Biopharma stock or one of its competitors? The main competitors of AEON Biopharma include Mana Capital Acquisition (MAAQ), Synergy CHC (SNYR), Rani Therapeutics (RANI), Dyadic International (DYAI), Estrella Immunopharma (ESLA), Rein Therapeutics (RNTX), Promis Neurosciences (PMN), Biodexa Pharmaceuticals (BDRX), Iterum Therapeutics (ITRM), and Kezar Life Sciences (KZR). These companies are all part of the "pharmaceutical products" industry. AEON Biopharma vs. Its Competitors Mana Capital Acquisition Synergy CHC Rani Therapeutics Dyadic International Estrella Immunopharma Rein Therapeutics Promis Neurosciences Biodexa Pharmaceuticals Iterum Therapeutics Kezar Life Sciences Mana Capital Acquisition (NASDAQ:MAAQ) and AEON Biopharma (NASDAQ:AEON) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment. Do insiders & institutionals believe in MAAQ or AEON? 68.4% of Mana Capital Acquisition shares are held by institutional investors. Comparatively, 22.8% of AEON Biopharma shares are held by institutional investors. 0.9% of AEON Biopharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is MAAQ or AEON more profitable? Company Net Margins Return on Equity Return on Assets Mana Capital AcquisitionN/A N/A N/A AEON Biopharma N/A N/A -994.63% Do analysts recommend MAAQ or AEON? AEON Biopharma has a consensus target price of $360.00, indicating a potential upside of 52,864.54%. Given AEON Biopharma's stronger consensus rating and higher possible upside, analysts clearly believe AEON Biopharma is more favorable than Mana Capital Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mana Capital Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, MAAQ or AEON? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMana Capital AcquisitionN/AN/AN/AN/AN/AAEON BiopharmaN/AN/A-$36.63M$298.120.00 Does the media prefer MAAQ or AEON? In the previous week, Mana Capital Acquisition's average media sentiment score of 0.00 equaled AEON Biopharma'saverage media sentiment score. Company Overall Sentiment Mana Capital Acquisition Neutral AEON Biopharma Neutral SummaryAEON Biopharma beats Mana Capital Acquisition on 4 of the 6 factors compared between the two stocks. Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEON vs. The Competition Export to ExcelMetricAEON BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.68M$785.89M$5.49B$9.54BDividend YieldN/A4.84%4.73%4.09%P/E Ratio3.781.3728.8323.83Price / SalesN/A25.68372.0766.02Price / CashN/A19.5635.4557.96Price / Book-0.166.758.275.54Net Income-$36.63M-$3.67M$3.25B$259.28M7 Day Performance-13.94%-4.77%-3.73%-4.68%1 Month Performance-19.08%-0.25%4.29%4.36%1 Year Performance-99.07%15.63%25.87%17.88% AEON Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEONAEON Biopharma3.3513 of 5 stars$0.68-6.5%$360.00+52,864.5%-99.2%$7.68MN/A3.785MAAQMana Capital AcquisitionN/A$4.39-4.2%N/A+875.0%$35.65MN/A0.001Gap DownSNYRSynergy CHC3.875 of 5 stars$3.72-1.8%$10.00+168.8%+3,260.0%$34.85M$34.83M0.0040Trending NewsRANIRani Therapeutics1.9036 of 5 stars$0.55+3.6%$7.33+1,231.2%-80.6%$33.63M$1.03M0.00110Negative NewsUpcoming EarningsShort Interest ↑DYAIDyadic International2.0793 of 5 stars$1.11+0.9%$6.00+440.5%-25.6%$33.10M$3.49M-5.557News CoveragePositive NewsESLAEstrella Immunopharma2.9551 of 5 stars$0.92+1.1%$16.00+1,639.1%-51.2%$32.91MN/A0.00N/ARNTXRein TherapeuticsN/A$1.41-3.4%N/AN/A$32.34MN/A0.009Positive NewsPMNPromis Neurosciences2.288 of 5 stars$0.90-8.8%$4.33+381.4%-46.8%$32.25MN/A0.005Upcoming EarningsShort Interest ↑Gap DownBDRXBiodexa Pharmaceuticals0.1034 of 5 stars$0.88flatN/AN/A$32.16M$470K0.0020News CoverageAnalyst DowngradeShort Interest ↑Gap DownITRMIterum Therapeutics1.5798 of 5 stars$0.78-2.8%$9.00+1,053.8%-37.7%$32.10MN/A-0.7910Upcoming EarningsShort Interest ↑Gap UpKZRKezar Life Sciences3.6576 of 5 stars$4.36+1.2%$39.50+806.0%-36.1%$31.49M$7M-0.4060Negative NewsAnalyst DowngradeShort Interest ↑ Related Companies and Tools Related Companies MAAQ Alternatives SNYR Alternatives RANI Alternatives DYAI Alternatives ESLA Alternatives RNTX Alternatives PMN Alternatives BDRX Alternatives ITRM Alternatives KZR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEON) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AEON Stock Alerts